NexgenRx Inc. (TSXV:NXG)

NexgenRx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26	20	16	19	28	17
Market Cap Growth	16.99%	26.04%	-16.75%	-33.75%	67.66%	23.08%
Enterprise Value	26	20	16	19	30	19
Last Close Price	0.36	0.27	0.20	0.24	0.35	0.21
PE Ratio	68.65	46.95	-	-	7.00	7.93
PS Ratio	1.52	1.19	1.12	1.46	2.38	1.59
PB Ratio	3.15	2.57	2.01	2.11	2.90	3.04
P/TBV Ratio	8.17	8.13	9.26	10.01	16.49	-
P/FCF Ratio	13.28	18.37	12.93	27.52	7.61	6.63
P/OCF Ratio	12.62	17.00	12.15	17.48	7.36	6.33
EV/Sales Ratio	1.54	1.20	1.13	1.48	2.51	1.83
EV/EBITDA Ratio	16.81	14.11	229.95	12.31	8.95	8.00
EV/EBIT Ratio	20.40	16.56	-	65.55	13.49	11.43
EV/FCF Ratio	13.42	18.63	13.02	27.84	8.02	7.62
Debt / Equity Ratio	0.06	0.07	0.06	0.05	0.04	0.26
Debt / EBITDA Ratio	0.33	0.36	3.62	0.26	0.11	0.55
Debt / FCF Ratio	0.26	0.50	0.39	0.64	0.11	0.57
Asset Turnover	0.54	0.54	0.50	0.46	0.43	0.46
Quick Ratio	0.12	0.11	0.12	0.13	0.14	0.06
Current Ratio	1.12	1.10	1.06	1.09	1.07	0.97
Return on Equity (ROE)	8.30%	8.01%	-4.01%	-0.24%	52.75%	57.48%
Return on Assets (ROA)	2.56%	2.47%	-0.32%	0.65%	5.03%	4.55%
Return on Capital (ROIC)	9.13%	9.16%	-1.03%	1.85%	16.09%	16.36%
Return on Capital Employed (ROCE)	14.80%	14.90%	-	3.10%	22.20%	27.00%
Earnings Yield	1.89%	3.14%	-2.14%	-0.12%	14.28%	12.61%
FCF Yield	7.53%	5.44%	7.74%	3.63%	13.14%	15.09%
Dividend Yield	2.78%	3.70%	4.91%	4.14%	-	-
Payout Ratio	133.40%	147.78%	-	-	3.25%	-
Buyback Yield / Dilution	-9.69%	-8.51%	-0.28%	6.01%	-0.88%	-6.10%
Total Shareholder Return	-6.71%	-4.81%	4.63%	10.15%	-0.88%	-6.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.